Vimarsana
Biggest News Aggregation in the World

Page 8 - Ocular Surface News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ocular Surface. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ocular Surface Today - Breaking & Trending Today

Bausch + Lomb and Novaliq Announce U.S. FDA Filing Acceptance for Investigational Treatment NOV03 (Perfluorohexyloctane) - Vimarsana News

Bausch + Lomb and Novaliq Announce U.S. FDA Filing Acceptance for Investigational Treatment NOV03 (Perfluorohexyloctane)

/PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to...

New species of Corynebacterium identified in the eyes of horses - Vimarsana News

New species of Corynebacterium identified in the eyes of horses

Better knowledge of the normal equine eye microbiota may help us understand its role in the development and progression of eye infections.

Non-invasive CGC examination for precision diagnosis of ocular surface diseases in live rabbit eyes - Vimarsana News

Non-invasive CGC examination for precision diagnosis of ocular surface diseases in live rabbit eyes

A Korean research team led by Professor Ki Hean Kim, Ph.D. candidates Seonghan Kim and Jungbin Lee (Department of Mechanical Engineering) at POSTECH, in collaboration with Professor Chang Ho Yoon (Department of Ophthalmology) of Seoul National University Hospital and Professor Young-Ho Jung (Department of Ophthalmology) of Eulji Hospital, has successfully demonstrated the non-invasive CGC examination in live rabbit eyes.

Dompé announces first patient enrolled in Phase 3 trial of cenegermin in patients with severe Sjögren's-related dry eye disease - Vimarsana News

Dompé announces first patient enrolled in Phase 3 trial of cenegermin in patients with severe Sjögren's-related dry eye disease

MILAN, Italy and SAN MATEO, Calif, Feb. 9, 2022 /PRNewswire/ -- Dompé farmaceutici S.p.A. and Dompé U.S. Inc. (collectively Dompé) announced today...

Dompé announces first patient enrolled in Phase 3 trial of cenegermin in patients with severe Sjögren's-related dry eye disease - Vimarsana News

Dompé announces first patient enrolled in Phase 3 trial of cenegermin in patients with severe Sjögren's-related dry eye disease

/PRNewswire/ -- Dompé farmaceutici S.p.A. and Dompé U.S. Inc. (collectively Dompé) announced today that the first patient has been enrolled in its Phase 3...